Early-onset ischaemic stroke: Analysis of 58 polymorphisms in 17 genes involved in methionine metabolism

Thrombosis and Haemostasis

Volumn 104, Issue 2, 2010, Pages 231-242

  Giusti, Betti ^a   Saracini, Claudia ^a   Bolli, Paola ^a   Magi, Alberto ^a   Martinelli, Ida ^b,c   Peyvandi, Flora ^b,c   Rasura, Maurizia ^d   Volpe, Massimo ^d,e   Lotta, Luca A ^b,c   Rubattu, Speranza ^d,e   Mannucci, Pier Mannuccio ^b,c   Abbate, Rosanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e IRCCS NEUROMED   (Italy)

Author keywords

Haplotype; Homocysteine; Ischaemic stroke; Methionine metabolism; Polymorphism

Indexed keywords

GENOMIC DNA; METHIONINE;

ADULT; AHCY GENE; AMINO ACID METABOLISM; ARTICLE; BHMT GENE; BHMT2 GENE; BRAIN ISCHEMIA; CBS GENE; CONTROLLED STUDY; ENOSF1 GENE; FEMALE; FOLH1 GENE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MTHFD1 GENE; MTHFR GENE; MTR GENE; MTRR GENE; NMT GENE; PON1 GENE; PON2 GENE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHMT1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC19A1 GENE; TCN2 GENE; TYMS GENE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HOMOCYSTEINE; HUMANS; ITALY; LOGISTIC MODELS; MALE; METHIONINE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 77955458833     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-11-0748     Document Type: Article

References (24)

1. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-128.
2. Nygård O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236. (Pubitemid 27310438)
3. Verhoef P, Hennekens CH, Malinow MR, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992; 268: 877-881.
4. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 2002; 325:1202-1206. (Pubitemid 35398783)
5. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002; 288: 2015-2022.
6. Wald DS, Wald NJ, Morris JK, et al. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. Br Med J 2006; 333: 1114-1117.
7. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 2005; 94: 907-915. (Pubitemid 41645928)
8. Lievers KJ, Kluijtmans LA, Blom HJ. Genetics of hyperhomocysteinaemia in cardiovascular disease. Ann Clin Biochem 2003; 40: 46-59.
9. Gellekink H, den Heijer M, Heil SG, et al. Genetic determinants of plasma total homocysteine. Semin Vasc Med 2005; 5: 98-109. (Pubitemid 40944286)
10. Sharma P, Senthilkumar RD, Brahmachari V, et al. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 2006; 5: 1.
11. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
12. Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172. (Pubitemid 28453294)
13. Perla-Kajan J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids 2007; 32: 561-572.
14. Waterland RA. Assessing the effects of high methionine intake on DNA methylation. J Nutr 2006; 136: 1706S-1710S.
15. Rubattu S, Speranza R, Ferrari M, et al. A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study. Eur J Neurol 2005; 12: 989-993. (Pubitemid 41820054)
16. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996; 143: 1257-1265. (Pubitemid 26178738)
17. Giusti B, Saracini C, Bolli P, et al. Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm. J Med Genet 2008; 45: 721-730.
18. Giusti B, Sestini I, Saracini C, et al. High-throughput multiplex single-nucleotide polymorphism (SNP) analysis in genes involved in methionine metabolism. Biochem Genet 2008; 46: 406-423.
19. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006; 78: 629-644.
20. Becker T, Cichon S, Jonson E, Knapp M. Multiple testing in the context of haplotype analysis revisited: application to case-control data. Ann Hum Genet 2005; 69: 747-756. (Pubitemid 41556327)
21. Becker T, Schumacher J, Cichon S, et al. Haplotype interaction analysis of unlinked regions. Genet Epidemiol 2005; 29: 313-322. (Pubitemid 41720950)
22. Bersano A, Ballabio E, Bresolin N, Candelise L. Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat 2008; 29: 776-795. (Pubitemid 351794129)
23. Sazci A, Ergul E, Tuncer N, et al. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C. Brain Res Bull 2006; 11: 45-50. (Pubitemid 44750419)
24. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007; 369: 1876-1882.